Wenbo Y. Zhu
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 119 publications
Anti-CTLA-4 antibody potentiates the antitumor effect of armed oncolytic virus OVM18 via enhancing intratumoral IL-18R1+CD8+ T cells.
Journal: Journal for immunotherapy of cancer
Published: August 24, 2026
Multiplex gene editing enables the multibiofortification of essential vitamins and other health-promoting phytonutrients in tomato.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 27, 2026
Simultaneous activation of apoptosis and cGAS-STING pathway with a mitochondria-targeted dehydrocholic acid compound for enhanced hepatocellular carcinoma chemoimmunotherapy.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 30, 2025
Sirolimus potentiates oncolytic Virus M1 efficacy through tumor-selective augmentation of viral replication.
Journal: Acta pharmacologica Sinica
Published: November 19, 2025
PROS1/AXL signaling protects mice from lethal influenza infection by inducing M2 macrophage polarization.
Journal: Acta biochimica et biophysica Sinica
Published: October 29, 2025
TAMs-mediated resistance to oncolytic virus M1 in solid tumors.
Journal: Journal for immunotherapy of cancer
Published: October 26, 2025
Retraction Note: DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage.
Journal: Nature communications
Published: October 24, 2025
Identification of YBX1 as an essential host RNA-binding protein governing tumor-selective replication of oncolytic virus M1.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: September 21, 2025
Oncolytic virus M1 reinvigorates CD8+ T-cell immunity against glioblastoma through B-cell-dependent antigen cross-presentation in the spleen.
Journal: Cellular & molecular immunology
Published: September 03, 2025
Last Updated: 09/26/2026